The Lowdown on Cancer focuses on the impact of cancer on lives and on the things that give us hope. From the pain of learning you have cancer to innovative new treatments offered by the best and brightest, we’ll give you the Lowdown.
Yes, cancer sucks. But you are not alone. And we are not without hope!
Supporting cancer research is good. It's important. It funds scientists and labs and countless "EUREKA!" moments in the lab that might help cancer patients. But research isn't the wole story. In fact, it's a very small part of the story. What happens...
"We know that 50% of humans will have cancer at some time in their life." Well if that wasn't enough of a gut punch, wait for this statistic: Of those people with cancer, 50% will be diagnosed with advanced tumors. Which means treatment options may be...
Meet Telexos GmbH. Telexos develops products for the clinical cancer research market and for the personalized cancer diagnostics market. Their focus is on the detection and analysis of rare cells in the blood, in particular circulating tumor cells (CTCs)...
Kent was traveling a lot for work, enjoying life with his wife, Bonnie, on the weekends. “Life was running smooth.” Then Kent discovered a lump in his breast, by his nipple. “Like any red-blooded American male, I ignored it!” It wasn’t until he noticed...
We asked which type of cancer warranted a deeper dive. You responded with Breast Cancer. And we listened. For women, breast cancer is the most common form of cancer, other than skin melanoma. The odds of developing breast cancer at some point in a woman's...
“I’m sorry, but you have breast cancer.”
I survived stage 3 breast cancer. While being infused with this new, life-saving medication, I often thought, “How did this medication get to me?”
Join us for this special update from Reglagene, the first company in CANCER FUND's portfolio of investments. Reglagene is working to develop targeted cancer therapies, delivered via oral medication, that control cancer cells' ability to become...
Research is only the first step when it comes to cancer innovations. But there are many more stops along the journey from lab to patient. And the catalyst behind it all? Funding, of course! Meet Jon Mengel from CANCER FUND, as he discusses the nearly 150...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer centers, and research institutions to raise awareness of the high-quality, innovative cancer research. But is it enough?...
Introducing our newest series, focusing on cancer diagnostics and monitoring. CANCER FUND Chief Medical Officer, Dr. Ajay Bhatnagar, joins us to chat about the current state of cancer diagnostic tools and potential paths forward to improve cancer...
We asked CANCER FUND founder and managing director, Anthony Bajoras, to share what drove him to start this impact venture fund. What do you regret today? What will you regret 10 years from now? 20? If you’re like me, your greatest regrets will be those...
Meet Greg O'Ryan Johnson, Venture Scout Associate. In his role at the CANCER FUND, Greg contributes by evaluating early stage companies through due diligence and analytical processes. Greg’s mission while at the CANCER FUND is to help entrepreneurs bring...
The innovators we speak with all have one major thing in common - yes, they're part of the fight against cancer, but more pressing is that the only road to the finish line requires FUNDING. That's why CANCER FUND was formed. We invest in cancer...
Meet Ajay Bhatnagar, MD, MBA, CANCER FUND's Chief Medical Officer, a practicing radiation oncologist, and a diverse business investor. Learn about his involvement with CANCER FUND, and how we are unlike any other firm in the investment space. In his...
It’s time to take a step back and pull aside the curtain to share with you the story behind CANCER FUND. Please join Ann as she speaks with CANCER FUND founder, Anthony Bajoras, for a very raw, emotional look at how this organization came to be, and how...
The Lowdown on Cancer was created to inspire and empower individuals touched by cancer to take an active role in bringing innovation to patients. If you're part of our community, then you're likely familiar with co-founder Ann Low. We wanted to take a...
Join us for our next journey: Is The Race for a Cure Stalled on a Treadmill? We’re diving in to give you a better look at why and how the CANCER FUND was created, and what work we are doing to improve the lives of cancer patients and those who love them....
Happy Thanksgiving from all of us at the CANCER FUND! https://youtu.be/elvieEws3Y4
Meet Richard Austin, CEO/President of Reglagene, a company out to discover and develop low-cost and noninvasive therapeutic solutions that regain control of genes exploited by cancer to keep patients responsive to treatment....
In our latest series, “The Bitch Is Back,” we have heard from community members about “The Problem,” their struggles with cancer recurrence. We’ve heard from the expert, Dr. Rachna Shroff, to better understand how cancer recurrence happens and how...
The second most feared words in cancer are “Your cancer is back.” Let’s dig deeply into cancer recurrence and see if we learn and find new hope. https://youtu.be/W-tSW40jN8E
The CANCER FUND is supporting The Lowdown and we have to shout them out! https://youtu.be/spgnrOZ6wWc
Your voice makes a difference in the innovation that CANCER FUND supports. Let’s talk about how to solve this access to care problem. https://youtu.be/GMsXMdnhkiw
We get the opportunity to answer a tough question from a Facebook Friend (Thank you for asking, Susan!) https://youtu.be/wh9etXCf7zg
View our 9/17 Community Forum and learn how CANCER FUND is working to improve Access to Care! https://youtu.be/JC8nEenusEE
What is the “Valley of Death” and how do companies get over it? https://youtu.be/sg3LNCSlEAo
Since we have a lot people asking how they can support our mission, this video introduces you to our sponsor - CANCER FUND - and provides info on how you can help support cancer innovation. https://youtu.be/2EHypLhx0CQ
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.
*BioAccel is tax-exempt under §501(c)(3) of the Internal Revenue Code, EIN 26-2751302.The mission of BioAccel is to accelerate the development of new companies and biomedical products by providing entrepreneurs with the needed training, mentoring, and early-stage funding support. Information concerning BioAccel including financial information, its purpose, and its tax returns, may be obtained without cost by writing to our principal place of business at the following address: BioAccel 4602 N 16th Street, Suite 303 Phoenix, AZ 85016, or by calling BioAccel at (602) 385-3210. Your contribution is deductible to the extent permitted by federal law and will help BioAccel meet its mission. Donations solicited and accepted by BioAccel are limited to: Arizona, Idaho, Wyoming, South Dakota, Nebraska, Vermont, and Puerto Rico.